dextrothyroxine has been researched along with Disease Exacerbation in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ab Wahab, S; An, N; Cheah, WK; Cheng, JT; Chidambaram, SK; Chow, TS; Hor, CP; Ker, HB; Khalid, KE; Khoo, SWR; King, TL; Koh, HM; Lai, NM; Lim, HH; Lim, SCL; Loh, JH; Low, LL; Mat Jelani, A; Mohd Unit, H; Nasruddin, AB; Peariasamy, KM; Song, LH; Tan, WH; Tay, KH; Zaid, M; Zaidan, NZ | 1 |
| Cid-López, MA; de la Rocha, C; Gómez-Méndez, SC; Gutiérrez-Dieck, GA; Hernández-Puente, CV; Iglesias-Palomares, C; Llamas-Velázquez, RA; Luna-Gudiño, N; Méndez-Del Villar, M; Mercado-Cerda, J; Mercado-Sesma, AR; Meza-Acuña, AI; Milenkovic, J; Pérez-Ríos, AM; Robles-Bojórquez, JG; Rosales-Galván, D; Sánchez-Ortiz, A; Tavares-Váldez, A; Valderrábano-Roldán, CG; Vargas-Íñiguez, B; Venegas-López, BI | 1 |
| Bidgoli, S; Colard, S; Van Bol, L | 1 |
| Crupie, MJ; Latif, Z | 1 |
| Byrne, P; Harrington, P; O Murchu, E; O'Neill, M; Ryan, M; Spillane, S | 1 |
| Barney, S; Blagburn, BL; Brawner, W; Cattley, R; Dillon, AR; Johnson, C; Rynders, P; Tillson, M; Welles, B | 1 |
| Weisenberg, SA | 1 |
| Assaf, RR; Wu, H | 1 |
| Biswas, G; Bradley, MH; Hooper, PJ; Ottesen, EA | 1 |
| AbdelRahman, SI; Ali, MM; Baraka, OZ; Homeida, MM; Mackenzie, CD; Sulaiman, SM; Williams, JF | 1 |
2 review(s) available for dextrothyroxine and Disease Exacerbation
| Article | Year |
|---|---|
Interventions in an Ambulatory Setting to Prevent Progression to Severe Disease in Patients With COVID-19: A Systematic Review.
Topics: Ambulatory Care; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Antiviral Agents; COVID-19; Disease Progression; Humans; Interferons; Ivermectin; Nitro Compounds; Polyethylene Glycols; Thiazoles | 2022 |
Visual Diagnosis: Severe Scaly Pruritic Rash in an 8-year-old Girl With Trisomy 21.
Topics: Administration, Oral; Antiparasitic Agents; Child; Disease Progression; Down Syndrome; Exanthema; Female; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Ivermectin; Physical Examination; Pruritus; Risk Assessment; Scabies; Severity of Illness Index; Treatment Outcome | 2016 |
2 trial(s) available for dextrothyroxine and Disease Exacerbation
| Article | Year |
|---|---|
Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities: The I-TECH Randomized Clinical Trial.
Topics: Adult; COVID-19; Disease Progression; Female; Hospital Mortality; Humans; Ivermectin; Middle Aged; SARS-CoV-2; Treatment Outcome | 2022 |
Ivermectin compared with placebo in the clinical course in Mexican patients with asymptomatic and mild COVID-19: a randomized clinical trial.
Topics: COVID-19; Disease Progression; Humans; Ivermectin; SARS-CoV-2; United States | 2022 |
6 other study(ies) available for dextrothyroxine and Disease Exacerbation
| Article | Year |
|---|---|
[Report of a new case of TINU syndrome].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Cross Infection; Diagnostic Errors; Disease Progression; Female; Humans; Hyperopia; Ivermectin; Kidney; Kidney Failure, Chronic; Lens, Crystalline; Methylprednisolone; Middle Aged; Nephritis; Nephritis, Interstitial; Prednisolone; Renal Dialysis; Scabies; Uveitis | 2019 |
Chronic strongyloidiasis: a case of B symptoms and recurrent asthma exacerbations.
Topics: Adrenal Cortex Hormones; Aged; Animals; Antiparasitic Agents; Asthma; Disease Progression; Eosinophilia; Feces; Humans; Ivermectin; Male; Recurrence; Strongyloides stercoralis; Strongyloidiasis | 2020 |
The progression of heartworm associated respiratory disease (HARD) in SPF cats 18 months after Dirofilaria immitis infection.
Topics: Animals; Cat Diseases; Cats; Dirofilaria immitis; Dirofilariasis; Disease Progression; Female; Filaricides; Ivermectin; Male; Respiratory Tract Infections; Specific Pathogen-Free Organisms | 2017 |
Chronic strongyloidiasis with recurrent asthma exacerbations and steroid-associated 'hives'.
Topics: Aged; Animals; Antiparasitic Agents; Asthma; Chronic Disease; Disease Progression; Eosinophilia; Humans; Ivermectin; Male; Recurrence; Steroids; Strongyloides stercoralis; Strongyloidiasis; Urticaria | 2018 |
The Global Programme to Eliminate Lymphatic Filariasis: health impact during its first 8 years (2000-2007).
Topics: Albendazole; Animals; Child; Communicable Disease Control; Disease Progression; Elephantiasis, Filarial; Filaricides; Global Health; Humans; Infant, Newborn; Infant, Newborn, Diseases; Ivermectin; Program Evaluation; Time Factors | 2009 |
Immune responses directed against microfilariae correlate with severity of clinical onchodermatitis and treatment history.
Topics: Animals; Anthelmintics; Antiparasitic Agents; Disease Progression; Humans; Ivermectin; Lymphocyte Activation; Lymphocytes; Microfilariae; Onchocerca volvulus; Onchocerciasis; Skin; Skin Diseases, Parasitic | 2003 |